The Obstetrician & Gynaecologist 2009;11:3:177-183
doi: 10.1576/toag.11.3.177.27502
Copyright © 2009 by the Royal College of Obstetricians and Gynaecologists.
Thrombocytopenia in pregnancy
Bethan Myers, MA FRCP FRCPath, Consultant Haematologist1
1. Department of Haematology, Nottingham University Hospitals NHS Trust, QMC Campus, Derby Road, Nottingham NG7 2UH, UK Email: Bethan.Myers{at}nuh.nhs.uk (corresponding author)
Key content:
- Thrombocytopenia occurs in 8–10% of all pregnancies.
- In pregnancy it is usually mild and benign.
- Rare causes can be associated with severe complications for mother and baby.
- Cases thought to be due to immune thrombocytopenic purpura or microangiopathic processes should be managed in a specialist centre.
Learning objectives:
- To learn about the underlying causes.
- To be aware of the management of the more severe cases.
- To ensure appropriate referral of high-risk cases.
Ethical issues:
- Clear prepregnancy counselling is important to enable women to make informed decisions regarding future pregnancies.
- Women need to understand the percentage risk of recurrence of certain conditions and the risks to fetal wellbeing.
Please cite this article as: Myers B. Thrombocytopenia in pregnancy. The Obstetrician & Gynaecologist 2009;11:177–183.
Keywords HELLP syndrome / immune (idiopathic) thrombocytopenic purpura / pre-eclampsia / thrombotic thrombocytopenic purpura
Copyright © 2009 by the Royal College of Obstetricians and Gynaecologists.